Tanezumab provides modest benefit for osteoarthritis

13:52 EDT 2 Jul 2019 | 2 Minute Medicine

1. In this randomized controlled trial, subcutaneous tanezumab resulted in moderate improvements in joint pain and physical function for patients with osteoarthritis compared to placebo. 2. Tanezumab-treated patients had more adverse events and more joint replacements. Evidence Rating Level: 1 (Excellent) Study Rundown: Nerve growth factor (NGF) is involved in pain signaling during osteoarthritis (OA), […]
Source: 2 Minute Medicine

Original Article: Tanezumab provides modest benefit for osteoarthritis


More From BioPortfolio on "Tanezumab provides modest benefit for osteoarthritis"

Quick Search

Relevant Topics

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...